Peter A. Thompson's Net Worth

$668 Million

Estimate Recalculated Feb 9, 2024 05:46PM EST

Who is Peter A. Thompson?

Peter A. Thompson has an estimated net worth of $668 Million. This is based on reported shares across multiple companies, which include Trubion Pharmaceuticals, Inc, PMV Pharmaceuticals, Inc., Mirati Therapeutics, Inc., ALPINE IMMUNE SCIENCES, INC., Janux Therapeutics, Inc., Edgewise Therapeutics, Inc., ProNAi Therapeutics Inc, Adaptimmune Therapeutics PLC, Prevail Therapeutics Inc., Synthorx, Inc., ARS Pharmaceuticals, Inc., Corvus Pharmaceuticals, Inc., Decibel Therapeutics, Inc., RESPONSE BIOMEDICAL CORP, Anthera Pharmaceuticals Inc, and Principia Biopharma Inc..

SEC CIK

Peter A. Thompson's CIK is 0001357522

Past Insider Trading and Trends

2016 was Peter A. Thompson's most active year for acquiring shares with 26 total transactions. Peter A. Thompson's most active month to acquire stocks was the month of May. 2021 was Peter A. Thompson's most active year for disposing of shares, totalling 20 transactions. Peter A. Thompson's most active month to dispose stocks was the month of February. 2020 saw Peter A. Thompson paying a total of $42,100,017.00 for 15,359,492 shares, this is the most they've acquired in one year. In 2020 Peter A. Thompson cashed out on 38,110,700 shares for a total of $372,624,766.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Trubion Pharmaceuticals, Inc No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Aug 27
Form 4
+48.79%
126.39K
$0.31
$39,622.32
385.42K
May 22
Form 4
0
0
Jan 30
Form 4
0
0
Jan 31
Form 4
+1.97%
5K
$10.06
$50,288.66
259.03K
Nov 19
Form 4
+0.39%
1K
$13.00
$13,000.00
255.03K
Oct 18
Form 3
0
0
No matching records found

PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.71

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 2
Form 4
7.06M
$18.00
$8,550,000.00
7.06M
Sep 25 - Sep 29
Form 3
0
0
No matching records found

Mirati Therapeutics, Inc. (MRTX) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

ALPINE IMMUNE SCIENCES, INC. (ALPN) Snapshot price: $27.23

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+6.40%
145.25K
$12.74
$1,850,497.74
2.42M
Jan 11
Form 4
0
0
Jan 2
Form 4
-13.05%
-1.55M
$19.37
-$28,671,733.76
10.31M
Dec 27 - Dec 28
Form 4
0
0
Jan 3
Form 4
0
0
Jan 3
Form 4
+32.91%
1.01M
$9.40
$9,499,987.80
4.08M
Sep 17
Form 4
0
0
Jan 4
Form 4
-16.34%
-600.00K
$14.25
-$8,550,000.00
3.07M
Dec 28
Form 4
0
0
Jan 2
Form 4
+11.29%
372.44K
$5.37
$1,999,997.43
3.67M
Jan 18
Form 4
0
0
Jan 2
Form 4
0
0
Jan 2
Form 4
3.3M
3.3M
Jul 24
Form 3
0
0
No matching records found

Janux Therapeutics, Inc. (JANX) Snapshot price: $8.76

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 14
Form 4
-1.60%
-40.40K
$20.30
-$820,120.00
2.49M
Dec 29
Form 4
-4.51%
-119.40K
$19.00
-$2,268,600.00
2.53M
Dec 21
Form 4
-12.93%
-393.30K
$19.07
-$7,500,231.00
2.65M
Dec 16
Form 4
3.04M
$17.00
3.04M
Jun 15
Form 4
0
0
Jun 10
Form 3
0
0
No matching records found